Recorded fact · drug.label_indication
drug.label_indication for rivaroxaban|coronary-artery-disease
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 6e679768 resolves to.
The record
| Fact id | 6e6797687218264d4ac13478 |
|---|---|
| Entity | drug: rivaroxaban|coronary-artery-disease |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260910 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) ( 1.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 015b4bb7dc4253efeb1e732de703070704eabf29b53b031bdd35d6ad663c692a.
The value
{
"ingredient": "RIVAROXABAN",
"conditionId": "coronary-artery-disease",
"conditionName": "Coronary artery disease",
"matchedAlias": "coronary artery disease",
"context": "risk-reduction",
"brand": "Xarelto",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "10db92f9-2300-4a80-836b-673e1ae91610",
"labelEffectiveTime": "20260910",
"labelsRead": 24,
"labelsNaming": 23,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 48189dabb0711f198d24e680ffdab47d2e10edda0f8ad61e3ad8cfee4bace07f.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.